BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29310512)

  • 1. Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
    Lee P; Knoebel RW; Pisano J; Pettit NN
    J Oncol Pharm Pract; 2019 Apr; 25(3):758-761. PubMed ID: 29310512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
    Przybylski DJ; Reeves DJ
    Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions.
    Lee SSF; Fulford AE; Quinn MA; Seabrook J; Rajakumar I
    Support Care Cancer; 2018 May; 26(5):1499-1504. PubMed ID: 29170868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia.
    Ganti BR; Marini BL; Nagel J; Bixby D; Perissinotti AJ
    Support Care Cancer; 2017 Feb; 25(2):541-547. PubMed ID: 27738797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
    Yemm KE; Barreto JN; Mara KC; Dierkhising RA; Gangat N; Tosh PK
    J Antimicrob Chemother; 2018 Jan; 73(1):204-211. PubMed ID: 29040595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity is not strongly associated with increased risk for febrile neutropenia during levofloxacin prophylaxis in patients with hematological malignancies receiving intermediate-risk myelosuppressive chemotherapy.
    Kurtti A; Fritz K; Elofson-Disney K; Benefield R
    J Oncol Pharm Pract; 2020 Sep; 26(6):1301-1305. PubMed ID: 31810423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Levofloxacin prophylaxis in neutropenic patients].
    Carena AA; Jorge L; Bonvehí P; Temporiti E; Zárate MS; Herrera F
    Medicina (B Aires); 2016; 76(5):295-303. PubMed ID: 27723617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis.
    Owattanapanich W; Chayakulkeeree M
    Hematology; 2019 Dec; 24(1):362-368. PubMed ID: 30880638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
    Ziegler M; Landsburg D; Pegues D; Bilker W; Gilmar C; Kucharczuk C; Gorman T; Bink K; Moore A; Fitzpatrick R; Stadtmauer EA; Mangan P; Kraus K; Han JH
    Biol Blood Marrow Transplant; 2019 May; 25(5):1004-1010. PubMed ID: 30481595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
    Kroll AL; Corrigan PA; Patel S; Hawks KG
    J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
    Wolf J; Tang L; Flynn PM; Pui CH; Gaur AH; Sun Y; Inaba H; Stewart T; Hayden RT; Hakim H; Jeha S
    Clin Infect Dis; 2017 Nov; 65(11):1790-1798. PubMed ID: 29020310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia.
    Rahman MM; Khan MA
    Bangladesh Med Res Counc Bull; 2009 Dec; 35(3):91-4. PubMed ID: 20922911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    Alexander S; Fisher BT; Gaur AH; Dvorak CC; Villa Luna D; Dang H; Chen L; Green M; Nieder ML; Fisher B; Bailey LC; Wiernikowski J; Sung L;
    JAMA; 2018 Sep; 320(10):995-1004. PubMed ID: 30208456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia.
    Uni M; Yoshimi A; Yamazaki S; Taoka K; Shinohara A; Nannya Y; Nakamura F; Kurokawa M
    Jpn J Clin Oncol; 2015 Aug; 45(8):745-8. PubMed ID: 25989991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
    Inaba H; Gaur AH; Cao X; Flynn PM; Pounds SB; Avutu V; Marszal LN; Howard SC; Pui CH; Ribeiro RC; Hayden RT; Rubnitz JE
    Cancer; 2014 Jul; 120(13):1985-92. PubMed ID: 24677028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
    De Rosa FG; Motta I; Audisio E; Frairia C; Busca A; Di Perri G; Marmont F
    BMC Infect Dis; 2013 Dec; 13():563. PubMed ID: 24289496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of early de-escalation of empiric antimicrobial therapy in acute leukemia patients with febrile neutropenia at a large academic medical center.
    Ly WJ; Brown EE; Pedretti Z; Auten J; Wilson WS
    J Oncol Pharm Pract; 2023 Mar; 29(2):305-310. PubMed ID: 34927495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin for Antibacterial Prophylaxis in Pediatric Patients With Acute Myeloid Leukemia or Undergoing Hematopoietic Stem Cell Transplantation.
    Patel B; Noda A; Godbout E; Stevens M; Noda C
    J Pediatr Pharmacol Ther; 2020; 25(7):629-635. PubMed ID: 33041718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A prospective, controlled, non-randomized study of three cohorts to test the effectiveness of two antibiotics levofloxacin and cotrimoxazol on antibacterial prophylaxis in neutropenic patients].
    Gracia Escudero A; Martín González M; Giménez Garrido F; Clavero Farré C; García Pérez MJ; Alvarez Corral G; Reyes Bertos A; Villegas Maldonado G; Rodríguez Cuartero A
    Med Clin (Barc); 2003 Mar; 120(9):321-5. PubMed ID: 12646106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin vs. levofloxacin for prophylaxis in recipients of hematopoietic stem cell transplantation.
    Rambaran KA; Seifert CF
    J Oncol Pharm Pract; 2019 Jun; 25(4):884-890. PubMed ID: 30041584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.